Low Barthel index score is a poor prognostic factor for newly diagnosed multiple myeloma patients

被引:2
|
作者
Geng, Chuanying [1 ]
Yang, Guangzhong [1 ]
Zhou, Huixing [1 ]
Wang, Huijuan [1 ]
Li, Yanchen [1 ]
Leng, Yun [1 ]
Zhang, Zhiyao [1 ]
Jian, Yuan [1 ]
Chen, Wenming [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hematol, Beijing 100020, Peoples R China
关键词
Multiple myeloma; Barthel index; Survival; Prognostic factors; GERIATRIC-ASSESSMENT; CRITERIA; FRAILTY;
D O I
10.1007/s10238-023-01002-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The basic activities of daily life may affect the prognosis of multiple myeloma (MM) patients and the Barthel index (BI) is currently the most widely used tool to evaluate basic activities of daily life, but few studies have evaluated its prognostic value in MM. We retrospectively enrolled patients with newly diagnosed MM and analyzed the association between the BI and the survival of newly diagnosed MM patients. We totally analyzed 538 patients and found that median overall survival (OS) and progression-free survival (PFS) were significantly shorter in the low BI (<= 85) group compared with the high BI (> 85) group. Univariate Cox proportional hazards regression analysis showed that the low BI was associated with shorter OS and PFS. It was also confirmed that the low BI was poor prognostic factor for OS and PFS in multivariable analyses. In the propensity score matching analysis, patients with low BI also had shorter OS and PFS. Our study suggested that the low BI was a poor prognostic factor for patients with newly diagnosed MM.
引用
收藏
页码:2593 / 2600
页数:8
相关论文
共 50 条
  • [41] Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
    Dytfeld, Dominik
    Jasielec, Jagoda
    Griffith, Kent A.
    Lebovic, Daniel
    Vesole, David H.
    Jagannath, Sundar
    Al-Zoubi, Ammar
    Anderson, Tara
    Detweiler-Short, Kristen
    Stockerl-Goldstein, Keith
    Ahmed, Asra
    Jobkar, Terri
    Durecki, Diane E.
    McDonnell, Kathryn
    Mietzel, Melissa
    Couriel, Daniel
    Kaminski, Mark
    Vij, Ravi
    Jakubowiak, Andrzej J.
    HAEMATOLOGICA, 2014, 99 (09) : E162 - E164
  • [42] Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics
    Vagnoni, Davide
    Travaglini, Fosco
    Pezzoni, Valerio
    Ruggieri, Miriana
    Bigazzi, Catia
    Dalsass, Alessia
    Mestichelli, Francesca
    Troiani, Emanuela
    Falcioni, Sadia
    Mazzotta, Serena
    Natale, Annalisa
    Angelini, Mario
    Ferretti, Silvia
    Angelini, Stefano
    Galieni, Piero
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (04) : 523 - 531
  • [43] Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas
    He, Zhen-Qiang
    Ke, Chao
    Al-Nahari, Fuad
    Duan, Hao
    Guo, Cheng-Cheng
    Wang, Yang
    Zhang, Xiang-Heng
    Chen, Yin-Sheng
    Liu, Zhi-Gang
    Wang, Jian
    Chen, Zhong-Ping
    Jiang, Xiao-Bing
    Mou, Yong-Gao
    JOURNAL OF NEURO-ONCOLOGY, 2017, 132 (02) : 239 - 247
  • [44] Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas
    Zhen-Qiang He
    Chao Ke
    Fuad Al-Nahari
    Hao Duan
    Cheng-Cheng Guo
    Yang Wang
    Xiang-Heng Zhang
    Yin-Sheng Chen
    Zhi-Gang Liu
    Jian Wang
    Zhong-Ping Chen
    Xiao-Bing Jiang
    Yong-Gao Mou
    Journal of Neuro-Oncology, 2017, 132 : 239 - 247
  • [45] The presence of two light chain bands on immunofixation is associated with poor outcomes in newly diagnosed multiple myeloma patients
    Ameni Jerbi
    Omar Turki
    Hend Hachicha
    Faten Kallel Sarbeji
    Sawsan Feki
    Sabrina Mejdoub
    Khaoula Kammoun
    Mohamed Ben Hmida
    Moez Elloumi
    Hatem Masmoudi
    Annals of Hematology, 2023, 102 : 1459 - 1466
  • [46] Low absolute CD4+ T cell counts in peripheral blood predict poor prognosis in patients with newly diagnosed multiple myeloma
    Gu, Yan
    Jin, Yuanyuan
    Ding, Jie
    Wu, Yujie
    Shi, Qinglin
    Qu, Xiaoyan
    Zhao, Sishu
    Li, Jianyong
    Chen, Lijuan
    LEUKEMIA & LYMPHOMA, 2020, 61 (08) : 1869 - 1876
  • [47] Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study
    Stege, Claudia A. M.
    Nasserinejad, Kazem
    Van der Spek, Ellen
    Bilgin, Yavuz M.
    Kentos, Alain
    Sohne, Maaike
    van Kampen, Roel J. W.
    Ludwig, Inge
    Thielen, Noortje
    Durdu-Rayman, Nazik
    de Graauw, Nicole C. H. P.
    van de Donk, Niels W. C. J.
    de Waal, Esther G. M.
    Vekemans, Marie-Christiane
    Timmers, Gert Jan
    van Der Klift, Marjolein
    Soechit, Savita
    Geerts, Paul A. F.
    Silbermann, Matthijs H.
    Oosterveld, Margriet
    Nijhof, Inger S.
    Sonneveld, Pieter
    Klein, Saskia K.
    Levin, Mark-David
    Zweegman, Sonja
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (25) : 2758 - +
  • [48] Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma
    Utsu, Yoshikazu
    Isono, Yuki
    Masuda, Shin-ichi
    Arai, Hironori
    Shimoji, Sonoko
    Matsumoto, Rena
    Tsushima, Takafumi
    Tanaka, Kazusuke
    Matsuo, Kosuke
    Kimeda, Chiharu
    Konno, Shiho
    Yano, Yudai
    Kuramoto, Nobuhiko
    Aotsuka, Nobuyuki
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 573 - 579
  • [49] Reduction rate of monoclonal protein as a useful prognostic factor in standard-risk group of newly diagnosed multiple myeloma
    Liu, Min
    Zhang, Jun-Yu
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (24) : 5643 - 5652
  • [50] Bone-Related Extramedullary Disease in Newly Diagnosed Myeloma Patients is an Independent Poor Prognostic Predictor
    Wang, Ying
    Liu, Aijun
    Xu, Tingting
    Yin, Jiahui
    Chen, Wenming
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16